Tower Research Capital LLC (TRC) - CLEARSIDE BIOMEDICAL INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$9,42710,836
+16831.2%
0.00%
Q1 2023$0
-100.0%
64
-97.4%
0.00%
Q3 2022$2,000
+100.0%
2,440
+260.4%
0.00%
Q2 2022$1,000
-94.7%
677
-91.9%
0.00%
Q1 2022$19,000
-45.7%
8,319
-34.2%
0.00%
-100.0%
Q4 2021$35,000
+94.4%
12,635
+328.7%
0.00%
Q3 2021$18,000
-56.1%
2,947
-82.3%
0.00%
-100.0%
Q1 2021$41,000
+215.4%
16,672
+252.6%
0.00%
Q4 2020$13,000
-31.6%
4,728
-62.1%
0.00%
Q3 2020$19,000
+850.0%
12,472
+1013.6%
0.00%
Q2 2020$2,000
-75.0%
1,120
-85.5%
0.00%
-100.0%
Q2 2019$8,000
+700.0%
7,722
+784.5%
0.00%
Q1 2019$1,000
-80.0%
873
-81.7%
0.00%
Q4 2018$5,000
-54.5%
4,779
+166.8%
0.00%
-100.0%
Q3 2018$11,000
-85.7%
1,791
-75.0%
0.00%
-75.0%
Q2 2018$77,000
-40.8%
7,174
-41.1%
0.00%
-63.6%
Q1 2018$130,000
+441.7%
12,175
+339.8%
0.01%
+450.0%
Q3 2017$24,0000.0%2,768
+2.9%
0.00%
-33.3%
Q4 2016$24,000
-85.2%
2,690
-71.1%
0.00%
-81.2%
Q3 2016$162,000
+3950.0%
9,321
+1764.2%
0.02%
Q2 2016$4,0005000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q4 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 3,917,622$7,365,0000.21%
GSA CAPITAL PARTNERS LLP 54,092$102,0000.06%
Carmignac Gestion 1,937,608$3,643,0000.05%
OXFORD FINANCIAL GROUP, LTD. LLC 91,824$173,0000.03%
SIGNATUREFD, LLC 121,351$228,0000.01%
Tekla Capital Management LLC 165,330$311,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 184,000$346,0000.01%
GROUP ONE TRADING, L.P. 567,903$1,068,0000.01%
Integrated Advisors Network LLC 15,700$30,0000.00%
WEDBUSH SECURITIES INC 22,900$43,0000.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders